Monoclonal antibodies (mAbs) have been a key therapeutic option for non-communicable diseases for decades, and a small number of mAbs have helped treat infectious diseases, including COVID-19. The ...

Monoclonal antibodies target specific disease molecules. They can help treat cancer, autoimmune disorders, and infectious diseases. Discover what you should know about this therapy. Monoclonal ...

Monoclonal antibodies (mAbs) are manufactured proteins that behave similarly to antibodies found naturally in the body. Researchers initially developed them for treating certain cancers but have now ...

On 7 August 1975, Nature published a paper that has had some of the greatest impacts on science and health care in modern times. The study, by biochemists Georges Köhler and César Milstein, described ...

Monoclonal antibodies (mAbs) make up one of the most important classes of advanced biotherapies. To find out about the current challenges and advances in the production of mAbs, GEN talked with Lukas ...

For the first time this fall, families will be offered season-long protection for infants and some children against respiratory syncytial virus (RSV). The US Food and Drug Administration (FDA) in July ...

Data supporting antibodies is limited compared to that for authorized vaccines. Despite more than 187 million Americans being fully vaccinated against COVID-19 and data and attestations from ...

In recent years, antibodies have become an incredibly popular therapeutic target – with monoclonal antibodies (mAbs) becoming an ever more widely used therapy for a number of diseases, including ...

As access to COVID-19 vaccines dwindles in the US, one company seems to be positioning its products as an alternative way of preventing the disease. Invivyd is the manufacturer of pemivibart, a ...

I n 2024, the U.S. Food and Drug Administration (FDA) approved the first monoclonal antibody for reducing food allergy reactions, including anaphylaxis, in adults and children age 1 year or older. The ...